Cargando...
Radiopharmaceutical Switch Maintenance for Relapsed Ovarian Carcinoma
Switch maintenance, or using alternative therapeutic agents that were not administered during a prior course of cancer treatment, has emerged as an active clinical research and regulatory agency-approvable path in the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP) drug-deve...
Guardado en:
| Publicado en: | Pharmaceuticals (Basel) |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7600139/ https://ncbi.nlm.nih.gov/pubmed/33008086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13100287 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|